Caron Products & Services, Inc.

Caron Products & Services, Inc. specializes in providing advanced environmental testing and incubation equipment tailored for laboratory applications, ensuring precise control over conditions for scientific research and development. Founded in 1985 and headquartered in the United States, Caron Products & Services, Inc. focuses on developing environmental chambers and incubators for research institutions and laboratories.

CEO Jay Hexamer leads the company, which has focused on enhancing its product offerings over the years. The company was recapitalized by SFW Capital Partners in January 2021, although the financial terms were not disclosed. Caron Scientific specializes in advanced environmental testing, incubation, and controlled environment equipment. Their product range includes stability and environmental chambers, growth chambers, cell culture incubators, and operator protection cabinets.

These products are essential for maintaining optimal conditions for research and product development across various sectors, including pharmaceuticals, biotechnology, and academic research. Caron's clientele includes a diverse array of research institutions and pharmaceutical companies, both within the United States and internationally, particularly in Europe and Asia. Caron Scientific generates revenue through a direct sales model, primarily serving clients in the life sciences sector. Their business-to-business agreements include the provision of operator manuals and service contracts alongside equipment sales, ensuring clients receive ongoing support.

The company’s core products, such as Class II biosafety cabinets and incubators, are designed for high-demand research environments, reflecting their commitment to functionality and reliability. Caron Products & Services, Inc. plans to launch new products designed to enhance laboratory capabilities, with specific launch dates and details yet to be disclosed. The company is targeting geographic expansion into new markets, particularly within Europe and Asia, aiming for a broader reach by the end of 2023.

The recent recapitalization in January 2021 will support these growth initiatives, allowing the company to invest in product development and market expansion.